Brief: Paxman applies for FDA approval for increased use of scalp cooling system
06/10/2017 07:02
Oct 6 (Reuters) - PAXMAN AB (PUBL) PAX.ST
* APPLIES FOR FDA APPROVAL IN US FOR SIGNIFICANTLY INCREASED
USE OF COMPANY'S SCALP COOLING SYSTEM
Source text for Eikon: ID:nWkr9vf5lH
Further company coverage: PAX.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Paxman AB (publ)
See all newsBrief: Paxman Secures First Uk Orders For Neuropathy System
Sweden's Paxman Q2 revenue rises 40% as net income turns positive
Brief: Paxman Reports Q2 Group Revenue Of SEK 105 Million
Brief: Paxman Says CMS Releases Cy2027 Proposed OPPS, MPFS Rules For Mechanical Scalp Cooling
Sweden's Paxman Q1 revenue rises 34% on Dignitana acquisition